Knokke-Heist (Belgium), 15 September 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) announces its participation at ExpoPharm 2025, one of Europe’s largest pharmaceutical trade fairs, held in Düsseldorf from 16 to 18 September 2025.
Category: Press Release
Post
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments
Knokke-Heist (Belgium), 5 September 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) announces that the capital increase previously under consideration has been cancelled, following a series of significant and positive business developments.
Post
Periocream: The Future Commercial Winner for bonyf
Knokke-Heist (Belgium), 11 August 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) is preparing to launch Periocream, a groundbreaking dental treatment designed exclusively for dental professionals. At bonyf, we expect our Notified Body to release the final report shortly, confirming the product’s readiness for market.
Post
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
Knokke-Heist (Belgium), 14 July 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) addresses the recent pressure on its share price and reaffirms its strong fundamentals, expanding global footprint, and ambitious roadmap for sustained growth.
Post
Annual Results 2024
Knokke-Heist (Belgium), 30 June 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2024 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
Post
bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India
Knokke-Heist (Belgium), 3 June 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) is proud to announce that Group Pharmaceuticals, a leading Indian oral health company, has become a significant stakeholder in bonyf NV.
Post
bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
Knokke-Heist (Belgium), 15 May 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) is pleased to announce the successful launch of its first exports to the United States through a new partnership with Honest Pharma, a U.S.-based healthcare company backed by Investment 360, an investor group with a strong track record of success across a range of global industries.
Post
bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
Knokke-Heist (Belgium), 8 April 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) announces that it has successfully advanced to Phase 3 in the development of its innovative Alginate-Organic Olive-oil based Denture Fixative Cream following a positive clinical-dermatological application study conducted by Dermatest GmbH (Germany).
Post
bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
Knokke-Heist (Belgium), 13 March 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents PerioTabs® and Periocream at the future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community. PerioTabs®-Periocream’s participation in this premier event highlights its potential to revolutionize dental care practices globally. Visit bonyf at the IDS Hall 5.2, Booth 131.
Post
bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy
Knokke-Heist (Belgium), 18 February 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) today announced its strategic plan to pursue a dual listing on the Nasdaq Stock Market while maintaining its current listing on Euronext Paris. This initiative is aimed at expanding the company’s global footprint, diversifying its investor base, and accelerating growth opportunities in the U.S. and international markets.